QA: Lixte Biotechnology Holdings INC in us_pharma/2013

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001335105_2014_Lixte_Biotechnology_Holdings_INC.pdf

Logs

warning Missing logo subcommand.report {}

Graph

Absolute values for 0001335105, Lixte Biotechnology Holdings INC

  xvar xval
0 AssetsCurrent 558,040
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 0
3 remainder_Assets 0
4 LiabilitiesCurrent 321,774
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 494,959
9 ResearchAndDevelopmentExpense 879,886
10 remainder_Expenses 0
11 remainder_Revenues 0
12 remainder_NetIncome 3.00
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 558,040
1 Liabilities 321,774
2 Expenses 1,374,845
3 Revenues 0
4 StockholdersEquity 236,266
5 NetIncome -1,374,842
6 ComprehensiveNetIncome -1,374,842
7 BaseVar 1,127,331
8 EconomicCapitalRatiobeforeLimitedLiability -1.95
9 EconomicCapitalRatio 1.04

Edgar->Model Mapping

Feature Distribution

Change over Time